Authors: BROUWER DAJ LEERINK CB STEWARD HN KROON TAJ SUVERKROPP GHJ ROMER JWP VOLMER M MUSKIET FAJ

Citation: Daj. Brouwer et al., LIPIDS, APOLIPOPROTEIN-E GENOTYPES AND OTHER RISK-FACTORS OF PATIENTSWITH CORONARY-ARTERY DISEASE IN CURACAO, West Indian Medical Journal, 46(2), 1997, pp. 47-52

Authors: BROUWER DAJ VANDERDIJS FPL LEERINK CB STEWARD HN KROON TAJ SUVERKROPP GHJ ROMER JWP VANDOORMAAL JJ MUSKIET FAJ

Citation: Daj. Brouwer et al., THE DIETARY FATTY-ACIDS OF PATIENTS WITH CORONARY-ARTERY DISEASE AND CONTROLS IN CURACAO - IMPLICATIONS FOR PRIMARY AND SECONDARY PREVENTION, West Indian Medical Journal, 46(2), 1997, pp. 53-56

Authors: LEERINK CB DEVRIES CVS VANDERKLIS FRM

Citation: Cb. Leerink et al., ELEVATED LEVELS OF SERUM LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPE ARE NOT RELATED TO PREECLAMPSIA, Acta obstetricia et gynecologica Scandinavica, 76(7), 1997, pp. 625-628

Authors: LEERINK CB DUIF PFCCM VERHOEVEN N HACKENG CM LEUS FR PRINS J BOUMA BN VANRIJN HJM

Citation: Cb. Leerink et al., APOLIPOPROTEIN(A) ISOFORM SIZE INFLUENCES BINDING OF LIPOPROTEIN(A) TO PLASMIN-MODIFIED DES-AA-FIBRINOGEN, Fibrinolysis, 8(4), 1994, pp. 214-220

Authors: LEERINK CB VANHAM ADFJ HEERES A DUIF PFCCM BOUMA BN VANRIJN HJM

Citation: Cb. Leerink et al., SULFHYDRYL COMPOUNDS INFLUENCE IMMUNOREACTIVITY, STRUCTURE AND FUNCTIONAL-ASPECTS OF LIPOPROTEIN(A), Thrombosis research, 74(3), 1994, pp. 219-232

Authors: LEUS FR LEERINK CB PRINS J VANRIJN HJM

Citation: Fr. Leus et al., INFLUENCE OF APOLIPOPROTEIN(A) PHENOTYPE ON LIPOPROTEIN(A) QUANTIFICATION - EVALUATION OF 3 METHODS, Clinical biochemistry, 27(6), 1994, pp. 449-455